CA Stock MarketDetailed Quotes

WLLW Willow Biosciences Inc

Watchlist
  • 0.075
  • 0.0000.00%
15min DelayMarket Closed Dec 13 16:00 ET
10.82MMarket Cap-1.50P/E (TTM)

Willow Biosciences Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
61.38%-908K
80.10%-733K
54.20%-1.75M
21.22%-10.92M
74.16%-1.07M
28.15%-2.35M
-8.10%-3.68M
-24.93%-3.82M
23.95%-13.86M
18.59%-4.13M
Net income from continuing operations
44.15%-1.25M
53.19%-1.69M
50.57%-2.36M
12.05%-13.03M
48.51%-2.42M
44.03%-2.23M
-14.38%-3.6M
-60.66%-4.77M
-141.27%-14.81M
9.41%-4.71M
Operating gains losses
----
----
-575.00%-135K
99.39%-23K
--0
96.71%-5K
100.12%2K
98.94%-20K
77.52%-3.76M
96.25%-45K
Depreciation and amortization
-43.73%314K
-20.50%353K
-22.12%352K
-30.80%1.83M
-22.75%377K
20.26%558K
-45.52%444K
-48.58%452K
-17.11%2.65M
-40.63%488K
Asset impairment expenditure
--0
--0
--0
--19K
--0
--0
--0
--19K
--0
--0
Remuneration paid in stock
118.79%65K
-32.05%106K
-70.08%158K
-71.25%420K
-59.20%82K
-194.79%-346K
-61.58%156K
7.98%528K
-14.21%1.46M
-61.93%201K
Deferred tax
----
----
----
---15K
----
----
----
----
--0
----
Other non cashItems
700.00%78K
95.00%39K
223.08%42K
-82.24%84K
828.57%65K
-109.92%-13K
-93.90%20K
85.71%13K
1,651.85%473K
-12.50%7K
Change In working capital
62.10%-119K
165.05%456K
568.29%192K
-260.47%-207K
1,330.43%849K
-234.04%-314K
-456.35%-701K
-109.81%-41K
140.82%129K
-215.00%-69K
-Change in receivables
----
--135K
110.59%18K
----
----
----
----
-2,733.33%-170K
----
----
-Change in inventory
----
--92K
-97.06%1K
----
----
----
----
88.89%34K
----
----
-Change in prepaid assets
----
--57K
-20.25%256K
----
----
----
----
9.93%321K
----
----
-Change in payables and accrued expense
----
--170K
29.20%-160K
----
----
----
----
-22,700.00%-226K
----
----
-Change in other working capital
----
--2K
--77K
----
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
61.38%-908K
80.10%-733K
54.20%-1.75M
21.22%-10.92M
74.16%-1.07M
28.15%-2.35M
-8.10%-3.68M
-24.93%-3.82M
23.95%-13.86M
18.59%-4.13M
Investing cash flow
Cash flow from continuing investing activities
-678.57%-109K
0
-96.12%135K
176.10%3.47M
100.17%6K
-110.45%-14K
99.89%-1K
1,159.76%3.48M
-171.98%-4.55M
-1,033.11%-3.46M
Capital expenditure reported
33.33%-20K
----
--0
9.24%-619K
-123.20%-58K
83.96%-30K
----
---524K
61.38%-682K
167.75%250K
Net PPE purchase and sale
--0
--0
--135K
-94.31%7K
-91.25%7K
--0
---7K
--0
3.36%123K
--80K
Net investment purchase and sale
-4.76%20K
--0
--0
199.50%4M
99.50%-20K
--21K
--1K
--4M
---4.02M
---4.02M
Net other investing changes
-2,080.00%-109K
----
----
196.15%77K
----
-101.80%-5K
101.34%5K
----
196.30%26K
265.63%234K
Cash from discontinued investing activities
Investing cash flow
-678.57%-109K
--0
-96.12%135K
176.10%3.47M
100.17%6K
-110.45%-14K
99.89%-1K
1,159.76%3.48M
-171.98%-4.55M
-1,033.11%-3.46M
Financing cash flow
Cash flow from continuing financing activities
660.00%644K
216.89%346K
140.80%71K
56.02%-318K
238.34%267K
33.53%-115K
-67.23%-296K
3.33%-174K
-102.12%-723K
19.25%-193K
Net issuance payments of debt
52.29%-198K
13.79%-200K
-13.79%-198K
70.68%-212K
413.92%609K
-139.88%-415K
-33.33%-232K
4.40%-174K
-13.50%-723K
-18.29%-194K
Net common stock issuance
----
--0
--270K
----
----
----
--0
--0
----
----
Proceeds from stock option exercised by employees
--1.1M
----
----
----
----
--0
----
----
----
----
Net other financing activities
-184.33%-253K
953.13%546K
---1K
---106K
---342K
--300K
-2,033.33%-64K
----
----
----
Cash from discontinued financing activities
Financing cash flow
660.00%644K
216.89%346K
140.80%71K
56.02%-318K
238.34%267K
33.53%-115K
-67.23%-296K
3.33%-174K
-102.12%-723K
19.25%-193K
Net cash flow
Beginning cash position
-89.33%690K
-84.52%1.62M
-71.43%3.15M
-63.45%11.01M
-80.03%3.68M
-70.70%6.47M
-60.28%10.47M
-63.45%11.01M
89.49%30.12M
-48.43%18.43M
Current changes in cash
84.96%-373K
90.28%-387K
-198.45%-1.54M
59.38%-7.77M
89.80%-793K
25.10%-2.48M
11.30%-3.98M
85.50%-517K
-234.54%-19.14M
-38.54%-7.78M
Effect of exchange rate changes
28.57%-5K
119.05%4K
181.82%18K
-442.31%-89K
-111.80%-42K
97.92%-7K
-110.29%-21K
88.83%-22K
2,700.00%26K
17,700.00%356K
Cash adjustments other than cash changes
281.73%547K
---547K
----
----
----
---301K
--0
----
----
----
End cash Position
-76.65%859K
-89.33%690K
-84.52%1.62M
-71.43%3.15M
-71.43%3.15M
-80.03%3.68M
-70.70%6.47M
-60.28%10.47M
-63.45%11.01M
-63.45%11.01M
Free cash from
61.02%-928K
80.14%-733K
59.73%-1.75M
20.66%-11.54M
71.00%-1.12M
31.17%-2.38M
6.27%-3.69M
-32.73%-4.34M
27.25%-14.54M
28.71%-3.88M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 61.38%-908K80.10%-733K54.20%-1.75M21.22%-10.92M74.16%-1.07M28.15%-2.35M-8.10%-3.68M-24.93%-3.82M23.95%-13.86M18.59%-4.13M
Net income from continuing operations 44.15%-1.25M53.19%-1.69M50.57%-2.36M12.05%-13.03M48.51%-2.42M44.03%-2.23M-14.38%-3.6M-60.66%-4.77M-141.27%-14.81M9.41%-4.71M
Operating gains losses ---------575.00%-135K99.39%-23K--096.71%-5K100.12%2K98.94%-20K77.52%-3.76M96.25%-45K
Depreciation and amortization -43.73%314K-20.50%353K-22.12%352K-30.80%1.83M-22.75%377K20.26%558K-45.52%444K-48.58%452K-17.11%2.65M-40.63%488K
Asset impairment expenditure --0--0--0--19K--0--0--0--19K--0--0
Remuneration paid in stock 118.79%65K-32.05%106K-70.08%158K-71.25%420K-59.20%82K-194.79%-346K-61.58%156K7.98%528K-14.21%1.46M-61.93%201K
Deferred tax ---------------15K------------------0----
Other non cashItems 700.00%78K95.00%39K223.08%42K-82.24%84K828.57%65K-109.92%-13K-93.90%20K85.71%13K1,651.85%473K-12.50%7K
Change In working capital 62.10%-119K165.05%456K568.29%192K-260.47%-207K1,330.43%849K-234.04%-314K-456.35%-701K-109.81%-41K140.82%129K-215.00%-69K
-Change in receivables ------135K110.59%18K-----------------2,733.33%-170K--------
-Change in inventory ------92K-97.06%1K----------------88.89%34K--------
-Change in prepaid assets ------57K-20.25%256K----------------9.93%321K--------
-Change in payables and accrued expense ------170K29.20%-160K-----------------22,700.00%-226K--------
-Change in other working capital ------2K--77K----------------------------
Cash from discontinued investing activities
Operating cash flow 61.38%-908K80.10%-733K54.20%-1.75M21.22%-10.92M74.16%-1.07M28.15%-2.35M-8.10%-3.68M-24.93%-3.82M23.95%-13.86M18.59%-4.13M
Investing cash flow
Cash flow from continuing investing activities -678.57%-109K0-96.12%135K176.10%3.47M100.17%6K-110.45%-14K99.89%-1K1,159.76%3.48M-171.98%-4.55M-1,033.11%-3.46M
Capital expenditure reported 33.33%-20K------09.24%-619K-123.20%-58K83.96%-30K-------524K61.38%-682K167.75%250K
Net PPE purchase and sale --0--0--135K-94.31%7K-91.25%7K--0---7K--03.36%123K--80K
Net investment purchase and sale -4.76%20K--0--0199.50%4M99.50%-20K--21K--1K--4M---4.02M---4.02M
Net other investing changes -2,080.00%-109K--------196.15%77K-----101.80%-5K101.34%5K----196.30%26K265.63%234K
Cash from discontinued investing activities
Investing cash flow -678.57%-109K--0-96.12%135K176.10%3.47M100.17%6K-110.45%-14K99.89%-1K1,159.76%3.48M-171.98%-4.55M-1,033.11%-3.46M
Financing cash flow
Cash flow from continuing financing activities 660.00%644K216.89%346K140.80%71K56.02%-318K238.34%267K33.53%-115K-67.23%-296K3.33%-174K-102.12%-723K19.25%-193K
Net issuance payments of debt 52.29%-198K13.79%-200K-13.79%-198K70.68%-212K413.92%609K-139.88%-415K-33.33%-232K4.40%-174K-13.50%-723K-18.29%-194K
Net common stock issuance ------0--270K--------------0--0--------
Proceeds from stock option exercised by employees --1.1M------------------0----------------
Net other financing activities -184.33%-253K953.13%546K---1K---106K---342K--300K-2,033.33%-64K------------
Cash from discontinued financing activities
Financing cash flow 660.00%644K216.89%346K140.80%71K56.02%-318K238.34%267K33.53%-115K-67.23%-296K3.33%-174K-102.12%-723K19.25%-193K
Net cash flow
Beginning cash position -89.33%690K-84.52%1.62M-71.43%3.15M-63.45%11.01M-80.03%3.68M-70.70%6.47M-60.28%10.47M-63.45%11.01M89.49%30.12M-48.43%18.43M
Current changes in cash 84.96%-373K90.28%-387K-198.45%-1.54M59.38%-7.77M89.80%-793K25.10%-2.48M11.30%-3.98M85.50%-517K-234.54%-19.14M-38.54%-7.78M
Effect of exchange rate changes 28.57%-5K119.05%4K181.82%18K-442.31%-89K-111.80%-42K97.92%-7K-110.29%-21K88.83%-22K2,700.00%26K17,700.00%356K
Cash adjustments other than cash changes 281.73%547K---547K---------------301K--0------------
End cash Position -76.65%859K-89.33%690K-84.52%1.62M-71.43%3.15M-71.43%3.15M-80.03%3.68M-70.70%6.47M-60.28%10.47M-63.45%11.01M-63.45%11.01M
Free cash from 61.02%-928K80.14%-733K59.73%-1.75M20.66%-11.54M71.00%-1.12M31.17%-2.38M6.27%-3.69M-32.73%-4.34M27.25%-14.54M28.71%-3.88M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Price
% Chg

No Data